Indian Exports Face $35 Billion Risk Under Proposed U.S. Tariff Regime

Indian Exports Face $35 Billion Risk Under Proposed U.S. Tariff Regime

A potential shift in United States trade policy under President-elect Donald Trump places approximately $30 billion to $35 billion of India’s annual merchandise exports at significant risk, according to a recent analysis by Tanvee Gupta Jain, Chief India Economist at UBS. As the incoming administration prepares to implement aggressive protectionist measures, Indian manufacturers and policymakers…

Read More
Indian Corporate Investment in the U.S. Hits $20.5 Billion Milestone

Indian Corporate Investment in the U.S. Hits $20.5 Billion Milestone

Indian corporations, spearheaded by the pharmaceutical sector, have committed a massive $20.5 billion in investments across the United States, signaling a deepening economic partnership between the two nations. The surge in capital inflow, which includes a notable $1.1 billion pledge made during the SelectUSA 2026 summit and Sun Pharma’s monumental $11.75 billion acquisition of Organon,…

Read More